Cornell University: Clinical Trials

5 trials sponsored by Cornell University, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 recruiting, 1 withdrawn. 5 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Completed 3, Recruiting 1, Withdrawn 1
Phase 21Completed 1

Follow Cornell University: new trials by email

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Increasing Affordable Fruits and Vegetables for Families With Food Insecurity
Veggie Vouchers - Diet
Phase 1RecruitingUniversity of South Carolina2962025-03-062025-04-04
Collagen-targeted Positron Emission Tomography (PET) Imaging for Assessment of EGCG Effect
EGCG 300 mg, Placebo for EGCG 300 mg, EGCG 600 mg - Idiopathic Pulmonary Fibrosis
Phase 1CompletedHal Chapman122024-02-072026-04-14
Study of Oral Epigallocatechin-3-gallate (EGCG) in IPF Patients
EGCG 300 mg + Nintedanib, EGCG 300 mg + Pirfenidone, Placebo 2 capsules + Nintedanib or Pirfenidone - Idiopathic Pulmonary Fibrosis
Phase 1CompletedHal Chapman502023-08-242026-04-14
MNGIE Allogeneic Hematopoietic Stem Cell Transplant Safety Study
Hematopoietic Allogeneic Stem Cells - Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE)
Phase 1WithdrawnMichio Hirano, MD2015-03-012022-08-01
The Effects of Omega-3 Fatty Acids on Aspirin Resistance
Aspirin, Lovaza, Both Aspirin and Lovaza - Increased Drug Resistance
Phase 1 / Phase 2CompletedUniversity of Rochester272008-11-012012-11-06

Conditions studied

Idiopathic Pulmonary Fibrosis (2)  ·  Cardiovascular Diseases (1)  ·  Myocardial Infarction (1)

Interventions

epigallocatechin gallate (2)  ·  Aspirin (1)  ·  Docosahexaenoic Acids (1)  ·  Fish Oils (1)  ·  Omacor (1)  ·  nintedanib (1)  ·  pirfenidone (1)

Countries

United States (4)

Top investigators

Fernando J Martinez, MD (1)  ·  Fernando Martinez, MD (1)  ·  Harold Chapman, MD (1)  ·  Michio Hirano, MD (1)  ·  Robert C Block, MD, MPH (1)  ·  Sydney Montesi (1)

Results publications

PMID 32160670, PMID 33472968, PMID 37116909

NIH funding

R01DK140677 (1), R33HL158540 (1), U54NS078059 (1)